Antifibrinolytic Agents for Hemoptysis Management in Adults with Cystic Fibrosis.

CONCLUSIONS: A pathway utilizing systemic antifibrinolytic therapy to treat hemoptysis in CF patients was associated with a reduction in hospital admissions. No serious adverse events were observed. Additional studies are needed to further define the benefits of systemic antifibrinolytic use in CF patients.
PMID: 30790551 [PubMed - as supplied by publisher]

Source: Chest - February 18, 2019 Category: Respiratory Medicine Authors: Al-Samkari H, Shin K, Cardoni L, Pighetti EH, Rits S, McMahon L, Perkins R, Uluer A, Connors JM Tags: Chest Source Type: research